Skip to main content

Erythropoieis-stimulating Agent (ESA) Therapy and Chronic Kidney Disease (CKD)

Last Update
Extension
.pdf
Print Code
WQ85-1493
Language
English
Creator
Renal Program

Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.

©2024 Nova Scotia Health Authority. All rights reserved.